Replies to post #135934 on Biotech Values

[hptaxis]

VSTM http://finance.yahoo.com/q?s=VSTM

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3
http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-sec

[mcbio]

Without reading the voluminous SEC filings, I couldn’t possibly answer your question.

Approach sounds interesting and novel but also doesn't look like they have anything even close to entering the clinic. There's no pipeline or much at all to speak of on their Web site. Guess they are mostly at the idea stage at this point.

[PennyStockInvestor]

Big time insider buying on BPAX stock. They know this stock is going up big time folks! BUY! BUY! BUY! They now have all the incentive to jack up the price per share on this stock BPAX.

2012-01-25
Option Award 2012-01-27
4:37 pm N/A
2022-01-24 BIOSANTE PHARMACEUTICALS INC BPAX Snabes Michael C
(Sr. VP of Medical Affairs) 165,000 $0.6844 165,000
(Direct) View
2012-01-25
Option Award 2012-01-27
4:33 pm N/A
2022-01-24 BIOSANTE PHARMACEUTICALS INC BPAX DONENBERG PHILIP B
(Sr VP of Finance, CFO, Secy) 285,000 $0.6844 285,000
(Direct) View
2012-01-25
Option Award 2012-01-27
4:29 pm N/A
2022-01-24 BIOSANTE PHARMACEUTICALS INC BPAX SIMES STEPHEN M
(Vice Chairman, President & CEO
Director) 800,000 $0.6844 800,000
(Direct) View